FECHAR
Feed

Já é assinante?

Entrar
Índice

Bibliografia

Última revisão: 25/10/2009

Comentários de assinantes: 0

Reproduzido de:

Manual de Controle de Doenças Sexualmente Transmissíveis – DST 4ª edição [Link Livre para o Documento Original]

Série Manuais n. 68

MINISTÉRIO DA SAÚDE

Secretaria de Vigilância em Saúde

Programa Nacional de DST e Aids

Brasília / DF – 2006

 

Bowden FJ, Garnett GP. Trichomonas vaginalis epidemiology: parameterising and analyzing a model of treatment interventions. Sex Transm Inf, 2000, 76: 248-256.

Brasil. Portaria no 542/1986. Diário Oficial da República Federativa do Brasil, Brasília, 24 de Dezembro de 1986, Seção 1.

Brasil. Ministério da Saúde. [www.aids.gov.br/documentos/publicações] – busca: conscritos do exército do Brasil, 2002

Brasil. Ministério da Saúde. PN-DST/AIDS. Estudo de prevalência das DST no Brasil. Mimeo. 2004a.

Brasil. Ministério da Saúde, [www.aids.gov.br/areatecnica/monitoraids/estudosespeciais] VII Pesquisa de Conhecimentos, atitudes e Práticas relacionadas ao HIV/aids com a População Brasileira de 15 a 54 anos – 2004b,

Brasil. Ministério da Saúde. Norma Técnica de Prevenção e Tratamento dos Agravos Resultantes da Violência Sexual contra Mulheres e Adolescentes. Brasília, 2004c.

Brasil. Ministério da Saúde. Boletim Epidemiológico DST e AIDS, ano II n.01-01 à 26a. semanas epidemiológicas – jan a jun de 2005.

Carvalho M, de Carvalho S, Pannuti CS, Sumita LM, de Souza VA. Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil. Int J Infect Dis. 1998-99 Winter;3(2):94-8.

CEBRAP, Ministério da Saúde. Relatório da pesquisa “ Comportamento Sexual da População Brasileira e Percepções do HIV/AIDS “. São Paulo, setembro de 2000.

Centers for Disease Control and Prevention (CDC). Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United State through childhood vacination. Recommendations of the Advisory Committee on Immunization Practices. A C.I.P. MMWR 42: 1-13, 1993.

Centers for Disease Control and Prevention (CDC). Increase in fluoroquinolone-resistant Neisseria gonorrhoeae – Hawaii and California, 2001. MMWR,2002;51(46):1041-44.

Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 2002 May 10;51(RR-6):1-78.

Centers for Disease Control and Prevention (CDC). Azithromycin treatment failures in syphilis infections--San Francisco, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 2004a Mar 12;53(9):197-8.

Centers for Disease Control and Prevention (CDC). Lymphogranuloma venereum among men who have sex with men--Netherlands, 2003-2004. MMWR Morb Mortal Wkly Rep. 2004b Oct 29;53(42):985-8.

Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, Zimba D, Vernazza PL, Maida M, Fiscus SA, Eron JJ Jr. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997 Jun 28; 349 (9069): 1868-73.

Corey L, Ashley R; Valacyclovir HSV Transmission Study Group. Prevention of herpes simplex virus type 2 transmission with antiviral therapy. Herpes. 2004 Aug;11 Suppl 3:170A-174A.

Dillon JA, Rubabaza JP, Benzaken AS, Sardinha JC, LI H, Bandeira MG, dos Santos Fernando Filho E. Reduced susceptibility to azythromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. Sex Transm Dis 2001, 28(9): 521-6.

Elley A, Pacey AA, Galdeiro M, Galdeiro M, Galdeiro F. Can Chlamydia trachomatis directly damage your sperm? Lancet Infect Dis. 2005 Jan;5(1):53-7.

Ferreira WA, Ferreira CM, Schettini APM, Sardinha JCG, Benzaken AS, Garcia MA, Garcia EG. Neisseria gonorrhoeae produtoras de betalactamase resistentes a azitromicina em Manaus, Amazonas, Brasil. DST- J Bras Doenças Sex Transm, 2004; 16(2):28-32.

Fioravante FC, Costa Alves Mde F, Guimaraes EM, Turchi MD, Freitas HA, Domingos LT. Prevalence of Chlamydia trachomatis in asymptomatic Brazilian military conscripts. Sex Transm Dis. 2005 Mar;32(3):165-9.

Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999 Feb;75(1):3-17.

Ghys PD, Fransen K, Diallo MO, Ettiegne-Traore V, Coulibaly IM, Yeboue KM, Kalish ML, Maurice C, Whitaker JP, Greenberg AE, Laga M. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d’Ivoire. AIDS. 1997 Oct;11(12):F85-93.

Gutman, L. Gonococcal diseases in infants and children. In: Holmes et al., eds. Sexually transmitted diseases. New York: McGraw-Hill Inc, 1999: 1146,Table 82-1.

Harper DM, Franco EL, Wheeler C, et al. Vaccination against human papillomavirus shows great promise. The Lancet 2004; 364(9447):1731-1732/1757-1765.

Holmes KK. Azitromycin versus penicillin for early syphilis.N Engl J Med 2005;305(12):1291-3.

Kapiga SH, Vuylsteke B, Lyamuya EF, Dallabetta G, Laga M. Evaluation of sexually transmitted diseases diagnostic algorithms among family planning clients in Dar es Salaam, Tanzania. Sex Transm Infect. 1998 Jun;74 Suppl 1:S132-8.

Karinen L, Pouta A, Hartikainen AL, Bloigu A, Paldanius M, Leunonen M, Saikku P, Jarvelin MR. Association between Chlamydia trachomatis antibodies and subfertility in the Northern Finland Birth Cohort 1966 (NFBC 1966), at the age of 31 years. Epidemiol Infect. 2004 Oct;132(5):977-84.

Kiddugavu MG, Kiwanuka N, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, Makumbi F, Li X, Reynolds SJ, Quinn TC, Gray RH; The Rakai Study Group.Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis. 2005 Jan;32(1):1-6.

Klebanoff MA, Hauth JC, MacPherson CA, Carey JC, Heine RP, Wapner RJ, Iams JD, Moawad A, Miodovnik M, Sibai BM, vanDorsten JP, Dombrowski MP; National Institute for Child Health and Development Maternal Fetal Medicine Units Network. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol, 2004 190(2) 363-70.

Leitich H, Bodner-Adler B, Brunbauer M, Kaider A Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003; 189:139-47.

Leone P. Asymptomatic shedding in the transmission, prevention, and treatment of genital herpes. Medscape Infectious Diseases, 2004;6(1)

Mardh PA. Tubal factor infertility, with special regard to chlamydial salpingitis. Curr Opin Infect Dis. 2004 Feb;17(1):49-52.

McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2005 Jan 25;(1): CD000262.

Miranda AE, Szwarcwald CL, Peres RL, Page-Shafer K Prevalence and risk behaviors for chlamydial infection in a population-based study of female adolescents in Brazil. Sex Transm Dis. 2004 Sep;31(9):542-6.

Moherdaui F, Vuylsteke B, Siqueira LF, dos Santos Junior MQ, Jardim ML, de Brito AM, de Souza MC, Willers D, Sardinha JC, Benzaken AS, Ramos MC, Bueno H, Rodrigues LG, Chequer PJ. Validation of national algorithms for the diagnosis of sexually transmitted diseases in Brazil: results from a multicentre study. Sex Transm Infect. 1998 Jun;74 Suppl 1:S38-43.

Moodley P, Sturm AW. Ciprofloxacin –resistant gonorrhoea on the rise in South Africa. Lancet 2005;366:1159.

Nieuwenhuis RF, Ossewaarde JM, Gotz HM, Dees J, Thio HB, Thomeer MG, Den Hollander JC, Neumann MH, Van Der Meijden WI. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis. 2004 Oct 1;39(7):996-1003. Epub 2004 Sep 08.

Passos MRL; Benzaken AS; Coelho ICB; Rodrigues GHS; Dutra JR JC; Varella R; Tavares RR; Barreto NA; Marques BP; Figueiredo J. Estudo de equivalência entre azitromicina e penicilina G benzatina no tratamento da sífilis. DST- J Bras Doenças Sex Transm 2004; 16(1):52-66.

Passos MRL, Nahn EPJr, Almeida GLF. Cancro Mole, in: Deesetologia, DST5 Mauro Romero Leal Passos - 5 ed. Rio de Janeiro: Cultura Médica, 2005 pag. 245-256.

Pinkerton SD, Abramson PR, Turk ME. Update estimates of condom effectiveness 1998. Journal of the Association of Nurses in Aids care. 9(6):88.

Rodriguez MDM, Obasi A, Mosha F, Todd J, Brown D, Changalucha J, Mabey D, Ross D, Grosskurth H, Hayes R. herpes simplex vírus type 2 infection increses HIV incidence: a prospective study in rural Tanzânia. AIDS, 2002; 16:451-462.

Sangani P, Rutherford G, Wilkinson D. Population-based interventions for reducing sexually transmitted infections, including HIV infection. Cochrane Database Syst Rev. 2004;(2):CD001220.

Schwebke JR. Diagnostic methods for bacterial vaginosis. Int J Obstet Gynecol, 1999; 67:S21-23.

Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 1997 Aug 23;350(9077):546-50. Erratum in: Lancet 1997 Oct 4;350(9083):1036.

Vuylsteke B. Current status of syndromic management of sexually transmitted infections in developing countries. Sex Transm Infect. 2004 Oct;80(5):392-4.

Watts DH; Brown ZA; Money D; Selke S; Huang, MI; Sacks MI; Corey L. A double-blind , randomized, placebo-controlled trial of acyclovir in late pregnancy in women for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003; 188:836-43.

Watson EJ, Templeton A, Russel I, Paavonen J, Mardh P-A, Stary A, Stray Pederson B. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol, 2002; 51:1021-31.

WendelL GD Jr, Stark BJ, Jamison RB, Molina RD, Sullivan TJ. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med. 1985 May 9;312(19):1229-32.

Wilkinson D, Ruterford G. Intervenciones poblacionales para la reduccion de infecciones de transmission sexual, incluída la infeccion por VIH. (Revision Cochrane traducida) La Cochrane Library plus in español, número 3, 2004. Oxford, Update Software Limited.

Wilkinson D, Ramjee G, Tholandi M, Ruterford G. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infection by women from men. The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons Ltd.

World Health Organization - Sexually Transmited Diseases: Policies and principles for prevention and care. WHO/UNAIDS, 1997.

World Health Organization - Guidelines for the management of sexually transmitted infections. 2003.

World Health Organization. Global Strategy for STI Prevention and Control Meeting. Geneva, Nov. 2004.

World Health Organization - Sexually Transmited and Other reproductive tract infections. A guide to essential practice. 2005.

 

SOBRE OS DIREITOS AUTORAIS DO DOCUMENTO

Consta no documento:

“Todos os direitos reservados. É permitida a reprodução parcial ou total desta obra, desde que citada a fonte e que não seja para venda ou qualquer fim comercial.”

O objetivo do site MedicinaNet e seus editores é divulgar este importante documento. Esta reprodução permanecerá aberta para não assinantes indefinidamente.

Conecte-se

Feed

Sobre o MedicinaNET

O MedicinaNET é o maior portal médico em português. Reúne recursos indispensáveis e conteúdos de ponta contextualizados à realidade brasileira, sendo a melhor ferramenta de consulta para tomada de decisões rápidas e eficazes.

Medicinanet Informações de Medicina S/A
Av. Jerônimo de Ornelas, 670, Sala 501
Porto Alegre, RS 90.040-340
Cnpj: 11.012.848/0001-57
(51) 3093-3131
info@medicinanet.com.br


MedicinaNET - Todos os direitos reservados.

Termos de Uso do Portal